Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Magaway

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Biochemical and Biophysical Research Communications|October 9, 2022
Comparative proteomics reveals elevated CCN2 in NGLY1-deficient cellsRebecca Hetz, Carlo Magaway, Jaylene Everett, et al.
Molecular Therapy. Nucleic Acids|January 16, 2025
Erratum: U1 Adaptor Oligonucleotides Targeting <i>BCL2</i> and <i>GRM1</i> Suppress Growth of Human Melanoma Xenografts <i>In Vivo</i>Rafal Goraczniak, Brian A Wall, Mark A Behlke, et al.
Molecular Therapy. Nucleic Acids|May 16, 2013
U1 Adaptor Oligonucleotides Targeting BCL2 and GRM1 Suppress Growth of Human Melanoma Xenografts In VivoRafal Goraczniak, Brian A Wall, Mark A Behlke, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Biochemical and Biophysical Research Communications|October 9, 2022
Comparative proteomics reveals elevated CCN2 in NGLY1-deficient cellsRebecca Hetz, Carlo Magaway, Jaylene Everett, et al.
Molecular Therapy. Nucleic Acids|January 16, 2025
Erratum: U1 Adaptor Oligonucleotides Targeting <i>BCL2</i> and <i>GRM1</i> Suppress Growth of Human Melanoma Xenografts <i>In Vivo</i>Rafal Goraczniak, Brian A Wall, Mark A Behlke, et al.
Molecular Therapy. Nucleic Acids|May 16, 2013
U1 Adaptor Oligonucleotides Targeting BCL2 and GRM1 Suppress Growth of Human Melanoma Xenografts In VivoRafal Goraczniak, Brian A Wall, Mark A Behlke, et al.
Pageof 1